Australia markets closed

InnoCan Pharma Corp (IP4.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
0.2090+0.0070 (+3.47%)
As of 10:35AM CEST. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-3,129
-3,764
-10,047
-9,953
-3,335
Depreciation & amortisation
35
35
43
40
23
Stock-based compensation
1,226
967
2,163
527
426
Change in working capital
-551
-531
-969
474
-127
Accounts receivable
-59
-15
2
-2
0
Inventory
-476
-621
-79
-430
0
Accounts payable
53
42
-474
500
27
Other working capital
-7,070
-6,093
-6,670
-3,687
-2,724
Other non-cash items
-83
125
-83
-24
4
Net cash provided by operating activities
-7,055
-6,067
-6,629
-3,687
-2,715
Cash flows from investing activities
Investments in property, plant and equipment
-15
-26
-41
-
-9
Other investing activities
-38
-5
-7
-
-
Net cash used for investing activities
-22
-31
-48
0
-9
Cash flows from financing activities
Debt repayment
-18
-11
-38
-39
-38
Common stock issued
2,897
0
3,914
2,761
4,492
Net cash used provided by (used for) financing activities
7,576
125
15,303
4,024
4,454
Net change in cash
550
-6,101
8,710
365
1,759
Cash at beginning of period
5,866
11,048
2,338
1,973
214
Cash at end of period
6,365
4,947
11,048
2,338
1,973
Free cash flow
Operating cash flow
-7,055
-6,067
-6,629
-3,687
-2,715
Capital expenditure
-15
-26
-41
-
-9
Free cash flow
-7,070
-6,093
-6,670
-3,687
-2,724